Market Update (NYSE:LLY): U.S. FDA warns on newer class of type 2 diabetes drugs

[Reuters – UK Focus] – The U.S. Food and Drug Administration on Friday warned that a widely used newer class of type 2 diabetes drug sold by AstraZeneca, Johnson & Johnson and Eli . . . → Read More: Market Update (NYSE:LLY): U.S. FDA warns on newer class of type 2 diabetes drugs Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Second-Quarter 2015 Dividend Company Update (NYSE:LLY): Lilly delays submission to market once-daily diabetes drug Market Update (NYSE:LLY): FDA approves Boehringer-Lilly drug for type-2 diabetes patients